Register entry

Aesica Queenborough Limited

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 6.

Dosage formNDCs
tablet, film coated6
RouteNDCs
Labeller name on the listingNDCs
aesica queenborough limited6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
-Ivacaftortablet, film coated43798-005DRUG FOR FURTHER PROCESSING
-Lumacaftor and Ivacaftortablet, film coated43798-004DRUG FOR FURTHER PROCESSING
-Lumacaftor/Ivacaftor Paediatrictablet, film coated43798-014DRUG FOR FURTHER PROCESSING
-Metformin Hydrochloride and Sitagliptin Phosphatetablet, film coated43798-001DRUG FOR FURTHER PROCESSING
-Metformin Hydrochloride and Sitagliptin Phosphatetablet, film coated43798-002DRUG FOR FURTHER PROCESSING
-Metformin Hydrochloride and Sitagliptin Phosphatetablet, film coated43798-003DRUG FOR FURTHER PROCESSING
Enquiry

Common questions

Is Aesica Queenborough Limited FDA approved?
Aesica Queenborough Limited holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Aesica Queenborough Limited make?
6 products are listed under Aesica Queenborough Limited in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.